Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 3Colonic Neoplasms 3Sarcopenia 2Prostatic Neoplasms 2Polycystic Ovary Syndrome 2Diarrhea 2Vaso-Occlusive Crises 1Stomach Neoplasms 1Seaweed Associated Changes in Healthy Subjects 1Rectal Neoplasms 1Proctitis 1Neoplasms 1Multiple Myeloma 1Mucositis 1Metabolic Syndrome 1Malnutrition 1Lymphoma 1Liver Failure 1Insulin Resistance 1Hyperandrogenism 1Head and Neck Neoplasms 1Glucose Intolerance 1Fibrosis 1Colonic Polyps 1Cholangiocarcinoma 1Chemotherapy-related Diarrhea 1Carcinoma, Hepatocellular 1Anovulation 1Anemia, Sickle Cell 1

Interventions

Metformin 10Clomiphene 10Inositol 3Medroxyprogesterone Acetate 2Letrozole 2Glycoprotein Hormones, alpha Subunit 2Folic Acid 2Chorionic Gonadotropin 2salicylsalicylic acid 1maltodextrin 1Vitamin D 1Ultrasonography 1Sodium Salicylate 1Raloxifene Hydrochloride 1Progestins 1Progesterone 1Nimodipine 1Lactalbumin 1Inulin 1Hematologic Tests 1Flutamide 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anovulation × maltodextrin × Clear all
NCT03864068 2026-01-07

INSUPP-PCOS

Milton S. Hershey Medical Center

Phase 2 Completed
154 enrolled

Anovulation, Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism, Glucose Intolerance

Data powered by HemOnc (CC BY 4.0) Colophon âš¡